Senior Manager, Clinical Site Contracts

Location
San Diego, CA, United States
Posted
Oct 12, 2020
Ref
405SN
Hotbed
Biotech Beach
Required Education
Bachelors Degree
Position Type
Full time
Fate Therapeutics is seeking a Senior Manager, Clinical Site Contracts responsible for the development of study-specific site budget templates and for the direct negotiation of site budgets with investigative sites. The Senior Manager, Clinical Site Contracts will also be responsible for partnering internally to support budget analysis and management activities. This is a full-time position located remotely in the San Francisco Bay Area or at our corporate headquarters in San Diego, CA reporting to the Director, Clinical Contracts.

Responsibilities
• Responsible for developing and negotiating clinical trial budgets with investigative sites, ensuring fair market value (FMV) compliance of clinical trial budgets, and managing the site clinical trial agreement (CTA) development timeline.
• Partners with Clinical Operations, Clinical Science, Finance and externally as needed to develop study specific site budget template and negotiation parameters.
• Partners with Clinical Operations and Legal to develop site contracting timelines, tracks progress and provides regular updates to internal partners and study teams.
• Partners with Legal to support delivery of fully executed CTAs.
• Identifies risk and escalates appropriately risk is identified during budget negotiation process.
• Uses internal and external data to perform site budget analysis and provide recommendations.
• Supports budget/forecasting and variance management activities as needed.
• Participate in the development and ongoing improvement of departmental processes and procedures.
• Supports negotiation of other budgets and performs other duties as required by the clinical department.
Knowledge/Skills/Abilities
• This role requires an in-depth knowledge of negotiations of clinical trial budgets, and an understanding of the drug development process and cross-functional responsibilities.
• Knowledgeable in the use of industry benchmarking data sets (e.g. Grantplan, Medicare, etc).
• Highly skilled in conflict resolution with the ability to resolve problems independently.
• Ability to multi-task within and across projects, prioritize and manage timelines effectively.
• Strong analytical and modeling skills; able to make data-driven recommendations.
• Strong interpersonal, communication and presentation skills to be able to engage with all levels both internally and externally.
• Self-motivated and adaptable to a dynamic environment with the ability to support successful change.
• Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities.
• Applies good judgement and professional expertise in new situations.

Qualifications
• BS/BA degree in related discipline and at least 5 years direct site budget negotiation experience.
• Experience within pharmaceutical/biotech industry required.
• Experience with oncology or cell-therapy preferred.
• Experience with US and global site budgets preferred.
• Experience with complex trial designs preferred.
• Thrive in an interactive, team-oriented culture.

Working Conditions and Physical Requirements
• Travel between office locations as required
• Occasional travel to meetings and conferences as required
• Occasional evening and weekend work will be required
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time. For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 405SN.

About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company's immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company's immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.